drugset / Trial / NCT04671056
Drug Interaction Study of MGL-3196 With Pioglitazone
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether the single-dose pharmacokinetics (AUC) of pioglitazone are affected by chronic dosing with MGL-3196 100 mg/day in healthy subjects.
Timeline
- Start
- 2018-11-09
- Primary completion
- 2018-12-11
- Completion
- 2019-01-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pioglitazone | Small molecule | 15 mg | Oral |
| Subject | Resmetirom | Small molecule | 100 mg | Oral |
Indications
No indication recorded.